Saskia
Saskia Braukmüller, Sarstedt DE
| Patent application number | Description | Published |
|---|---|---|
| 20090211449 | Method for separating gas - Gas mixtures containing HF, HCl or HBr and other constituents, in particular gas mixtures containing carboxylic acid fluorides, C(O)F | 08-27-2009 |
Saskia Braukmüller, Sarstedt DE
| Patent application number | Description | Published |
|---|---|---|
| 20090211449 | Method for separating gas - Gas mixtures containing HF, HCl or HBr and other constituents, in particular gas mixtures containing carboxylic acid fluorides, C(O)F | 08-27-2009 |
Saskia Brunner-Agten, Bern CH
| Patent application number | Description | Published |
|---|---|---|
| 20120094286 | GENE DOSAGE ANALYSIS - The present invention relates to methods of detecting the presence of a genetic polymorphism within two or more closely linked, homologous genes, for example α-thalassemia, in a sample using RT-PCR by subjecting the sample to separate amplification reactions using (a) a pair of forward and reverse primers specific for the head region of each of said two or more closely linked, homologous genes and (b) a pair of forward and reverse primers specific for the tail region of each of said two or more closely linked, homologous genes; and detecting and quantitating the amplification products relative to a control product. | 04-19-2012 |
Saskia Dege, Hamburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20150360769 | HIGH LIFT SYSTEM FOR AN AIRCRAFT, AIRCRAFT HAVING A WING AND A HIGH LIFT SYSTEM AND METHOD FOR MOVING A HIGH LIFT SURFACE RELATIVE TO THE WING OF AN AIRCRAFT - A high lift system for an aircraft, comprises a drive unit, a high lift surface, at least one primary drive station, each primary drive station having a shaft connection couplable with the drive unit and a primary lever couplable with the high lift surface. The high lift system further comprises at least one secondary unit, each secondary unit having a secondary lever couplable with the high lift surface. Each one of the at least one primary drive station is adapted for moving the respective primary lever on driving the shaft connection, and each one of the at least one secondary unit comprises a selectively activatable brake, such that the secondary lever follows the motion of the one of the at least one high lift surface when the brake is deactivated. | 12-17-2015 |
Saskia Feast, San Rafael, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20140201058 | Stewardship Method for Managing Ozone-Depleting Substances - A stewardship system integrates the management of ozone depleting substances and halogenated substances, such as chlorofluorocarbons (CFC), across multiple players in the supply chain, carbon credit generation, sale of carbon credits within the various carbon credit markets, and improves distribution of the profits to the contributing entities. A central processing entity mediates transactions between the different entities. | 07-17-2014 |
| 20150161574 | STEWARDSHIP METHOD FOR MANAGING OZONE-DEPLETING SUBSTANCES - A stewardship system integrates the destruction of ozone depleting substances, such as chlorofluorocarbons (CFC), carbon credit generation, sale of carbon credits within the various carbon credit markets, and distribution of the profits to the contributing entities. A central processing entity mediates transactions between the different entities. | 06-11-2015 |
Saskia Klee-Laquai, Hilden DE
| Patent application number | Description | Published |
|---|---|---|
| 20100136130 | Preparation for the Controlled Release of Bioactive Natural Substances - The present invention relates to a preparation comprising at least one encapsulation material and at least one bioactive natural substance, which bioactive natural substance can be released from the preparation in a controlled manner, wherein the encapsulation material comprises at least one glyceride with a melting point of at least 35° C. and additionally at least one polymer with polyester units, which has a melting temperature of at least 30° C. and a viscosity in the range from 50 mPa*s to 250 Pa*s, measured by means of rotational viscometry at 110° C. The present invention further describes processes for producing the preparation of the invention, as well as preferred uses. | 06-03-2010 |
Saskia Mueller-Meskamp, Munchen DE
| Patent application number | Description | Published |
|---|---|---|
| 20140303393 | Process For Preparing Sulfates And/Or Sulfonates In A Micro-Reaction System - Suggested is a process for preparing sulfates and/or sulfonates by adding sulfur trioxide to a compound comprising at least one hydroxyl function and/or at least one double bond, which is characterized in that | 10-09-2014 |
Saskia Stahlecker-Voslamber, Leiden NL
| Patent application number | Description | Published |
|---|---|---|
| 20100203523 | MEANS AND METHODS FOR CLASSIFYING SAMPLES OF MULTIPLE SCLEROSIS PATIENTS - The invention in one aspect provides a method for classifying cells from a human individual said method comprising: providing a sample comprising cells from said individual that are typically responsive to exposure to a type I interferon; determining a level of activity of a pathway that is modulated by type 1 interferon; and classifying said cells on the basis of the determined level of activity. Cells present in said sample are preferably cultured said cells in the presence of a type I interferon prior to determining a level of activity of said pathway. This is activity is preferably compared to the activity of said pathway in cells in said sample prior to said culture. Preferably the sample is from an individual that is not treated with a type I interferon prior to collecting said sample. Preferably the method is used to determine, prior to initiating treatment with a type I interferon, whether said individual is likely to be a good, a normal or a poor responder to the contemplated treatment. | 08-12-2010 |
| 20140094378 | MEANS AND METHODS FOR CLASSIFYING SAMPLES OF MULTIPLE SCLEROSIS PATIENTS - The invention in one aspect provides a method for classifying cells from a human individual said method comprising: providing a sample comprising cells from said individual that are typically responsive to exposure to a type I interferon; determining a level of activity of a pathway that is modulated by type I interferon; and classifying said cells on the basis of the determined level of activity. Cells present in said sample are preferably cultured said cells in the presence of a type I interferon prior to determining a level of activity of said pathway. This is activity is preferably compared to the activity of said pathway in cells in said sample prior to said culture. Preferably the sample is from an individual that is not treated with a type I interferon prior to collecting said sample. Preferably the method is used to determine, prior to initiating treatment with a type I interferon, whether said individual is likely to be a good, a normal or a poor responder to the contemplated treatment. | 04-03-2014 |
Saskia Tromp-Van Den Bogaerdt, Best NL
| Patent application number | Description | Published |
|---|---|---|
| 20090015128 | LIGHT EMITTING DEVICE WITH ELECTRODE COMPRISING A CERAMIC MATERIAL - The invention relates to a light-emitting device comprising an electrode with a ceramic oxide material, which is brought in to contact with a reducing agent or a precursor thereof. The reducing agent serves to bind the released oxygen and to control the performance of the light-emitting device. | 01-15-2009 |
Saskia Valtiner-Zuegg, Lienz AT
| Patent application number | Description | Published |
|---|---|---|
| 20150224411 | Entertainment device comprising suspended simulation platform - An entertainment device includes a screen on which a film can be shown, a movable simulation platform, a multiplicity of audience places or locations disposed on the simulation platform, each place or location having a supporting element for spectators to lean against, a drive device for moving the simulation platform, and a controlling or regulating unit for controlling or regulating the movement of the simulation platform. The movable simulation platform can be moved by the drive device under control of the controlling or regulation unit in dependence on a motion data track corresponding to the film. The simulation platform is suspended from cables which can be moved by the drive device. | 08-13-2015 |
Saskia Van Dantzig, Utrecht NL
| Patent application number | Description | Published |
|---|---|---|
| 20140276243 | BEHAVIORAL RISK ANALYZER AND APPLICATION THAT ESTIMATES THE RISK OF PERFORMING UNDESIRED BEHAVIOR - A method for coaching a subject, including receiving data corresponding to at least one of a desired behavior of the subject or an undesired behavior of the subject, receiving a level of available self control of the subject via an input source, calculating a level of required self control needed to perform the desired behavior or suppress the undesired behavior, analyzing a risk based on the level of available self control and the level of required self control, where the risk is associated with predicting whether the subject will perform the undesired behavior or not perform the desired behavior, and intervening when the risk analyzed is above a particular threshold. | 09-18-2014 |
Saskia Van De Zande, Boxmeer NL
| Patent application number | Description | Published |
|---|---|---|
| 20080292659 | Prime Boost Vaccine for the Protection of Equines Against Equine Influenza - The present invention is concerned with vaccinating equines against the equine influenza virus (EIV). | 11-27-2008 |
| 20100233208 | Methods of Treating and Preventing Neurological Symptoms Caused by Avian Reovirus and Novel Associated Characteristics - Embodiments of the present invention generally relate to novel methods for the treatment and/or prevention of neurological symptoms caused by an avian reovirus, enteric reovirus strain (ERS), and associated characteristics. Other embodiments generally comprise and immunogenic composition or vaccine comprising an ERS for the treatment and/or prevention of neurological symptoms. | 09-16-2010 |
Saskia Van De Zande, Geel BE
| Patent application number | Description | Published |
|---|---|---|
| 20080213304 | Methods of Treating and Preventing Neurological Symptons Caused by Avian Reovirus and Novel Associated Characteristics - Embodiments of the present invention generally relate to novel methods for the treatment and/or prevention of neurological symptoms caused by an avian reovirus, enteric reovirus strain (ERS), and associated characteristics. Other embodiments generally comprise and immunogenic composition or vaccine comprising an ERS for the treatment and/or prevention of neurological symptoms. | 09-04-2008 |
Saskia Vermeer-Van Der Laar, Boxtel NL
| Patent application number | Description | Published |
|---|---|---|
| 20080280284 | Nucleic Acid Sequences That Can Be Used as Primers and Probes in the Amplification and Detection of Hsv Dna and Method for the Amplification and Detection of Hsv Dna Using a Transcription Based Amplification - The present invention is related to a pair of oligonucleotide primers for the amplification of HSV nucleic acid comprising: a) an oligonucleotide, 10-50 nucleotides in length, preferably 10-35 nucleotides in length, comprising at least a fragment of 10 nucleotides of a sequence selected from the group consisting of: 5′-ACGTTCACCAAGCTGCTGCT-3′, or its complementary sequence and b) an oligonucleotide, 10-50 nucleotides in length, preferably 10-35 nucleotides in length, comprising at least a fragment of 10 nucleotides of a sequence selected from the group consisting of: 5′CCAGGGCCCTGGAGGTGCGG-3′, or its complementary sequence. The invention also relates to probes, method for amplifying an HSV DNA target, method of specific ou aspecific detection of HSV type 1 and 2 and test kit to do possible the detection of HSV. The present invention is especially useful in methods for practicing nucleic acid test. | 11-13-2008 |
Saskia Vertaik, Oss NL
| Patent application number | Description | Published |
|---|---|---|
| 20140256725 | FSH RECEPTOR ANTAGONISTS - The invention relates to FSH receptor antagonist according to general formula I or a pharmaceutically acceptable salt thereof and to a pharmaceutical composition containing the same. The compounds can be used for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, and for the treatment of uterine fibroids and other menstrual-related disorders. | 09-11-2014 |
Saskia Wolf, Hamburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20110137023 | METHOD FOR PRODUCING PHOSPHATE-BRIDGED NUCLEOSIDE CONJUGATES - The invention relates to a method for producing phosphate-bridged nucleoside conjugates. In the method a nucleophile is first dissolved in a non-aqueous solvent and dried, and a cyclosaligenyl phosphate compound is subsequently added to the solution. | 06-09-2011 |